FACT Accreditation lets Tennessee Oncology bring community oncology CAR T-cell therapy closer to home, expanding access for non-Hodgkin lymphoma patients.
|Articles|February 1, 1998
The American Journal of Managed Care
- February 1998
- Volume 4
- Issue 2
Outcomes for Control Patients Referred to a Pediatric Asthma Outreach Program: An Example of the Hawthorne Effect
Advertisement
Articles in this issue
over 28 years ago
Physicians' Perceptions of Managed Careover 28 years ago
The Pharmacoeconomic Benefits of Cholesterol Reductionover 28 years ago
The Neonatologist as Primary Care Physicianover 28 years ago
Menopause and Controversies in Hormone Replacement Therapyover 28 years ago
An Update on the Treatment of Premenstrual Syndromeover 28 years ago
Physicians' Perceptions of Managed CareAdvertisement
Related to this article
The analysis found a nonlinear association between systemic inflammation and overactive bladder, with stronger links at higher inflammation levels.
A real-world study found that adding a GLP-1 to SGLT2 inhibitor therapy was associated with lower kidney, cardiovascular, and mortality risks in CKD.
In experiments at MD Anderson, rising CD70 helps mantle cell lymphoma evade immunity; a CD70×CD3 bispecific restores T-cell killing and prolongs survival in resistant models.
The NPS index, ranging from –100 to +100, serves as a proxy for customers’ willingness to recommend products and services they themselves have used.
North Carolina experts discussed CLL, breast cancer, and myeloma treatments and how to expand access to complex cancer care beyond academic centers.
The IRA's Medicare out-of-pocket cap is easing costs for patients with cancer, but community oncology leaders warn price cuts are straining practices.
A survivor shares axi-cel therapy highs, experiences with severe CRS and neurotoxicity, and why access to care and clinical trials improves QOL.
Advertisement
Advertisement
Trending on AJMC
1
Tavapadon for Parkinson Disease Approved by FDA
2
Medicare Cap Eases Patient Costs as Negotiation Squeezes Practices
3
Access and Innovation in North Carolina’s Research Triangle
4
Biomarker-Driven Care Is Racing Ahead of the Systems Built to Support It
5